Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:CCM NASDAQ:KDLY NASDAQ:NAKA NASDAQ:SERA On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCCMConcord Medical Services$5.19-5.7%$5.69$3.80▼$10.77$23.88M-0.9422,253 shs9,392 shsKDLYKindly MD$13.25+19.5%$12.27$0.65▼$34.77$79.79MN/A2.29 million shs1.14 million shsNAKAKindlyMD$15.02+13.4%$12.15$0.65▼$34.77$100.78M34.35554,710 shs885,260 shsSERASera Prognostics$2.25-2.2%$2.46$1.37▼$9.13$86.65M0.99109,515 shs62,052 shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCCMConcord Medical Services+5.49%+6.43%+3.95%-30.82%-30.38%KDLYKindly MD-22.34%+53.18%-9.84%-19.99%+597.53%NAKAKindlyMD+19.48%+74.11%+9.59%+1,324,999,900.00%+1,324,999,900.00%SERASera Prognostics+3.14%-16.36%-16.67%-3.36%-67.38%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCCMConcord Medical ServicesN/AN/AN/AN/AN/AN/AN/AN/AKDLYKindly MDN/AN/AN/AN/AN/AN/AN/AN/ANAKAKindlyMDN/AN/AN/AN/AN/AN/AN/AN/ASERASera Prognostics0.7198 of 5 stars0.02.00.00.02.02.50.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCCMConcord Medical Services 0.00N/AN/AN/AKDLYKindly MD 0.00N/AN/AN/ANAKAKindlyMD 0.00N/AN/AN/ASERASera Prognostics 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCCMConcord Medical Services$52.60M0.43N/AN/A$51.05 per share0.10KDLYKindly MD$2.47M32.30N/AN/AN/A∞NAKAKindlyMD$2.72M42.02N/AN/A$1.18 per share12.73SERASera Prognostics$80K1,059.47N/AN/A$2.34 per share0.96Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCCMConcord Medical Services-$42.23MN/A0.00∞N/AN/AN/AN/AN/AKDLYKindly MDN/A-$0.77N/A∞N/AN/AN/AN/AN/ANAKAKindlyMD-$3.62M-$0.86N/A∞N/A-244.00%-131.09%-106.04%N/ASERASera Prognostics-$32.90M-$0.85N/AN/AN/A-30,306.48%-45.86%-34.31%N/ALatest CCM, KDLY, SERA, and NAKA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/6/2025Q2 2025SERASera Prognostics-$0.21-$0.16+$0.05-$0.16$0.05 million$0.02 million8/5/2025Q2 2025NAKAKindlyMDN/A-$0.34N/A-$0.35N/A$0.41 million5/14/2025Q1 2025SERASera Prognostics-$0.24-$0.20+$0.04-$0.20$0.06 million$0.04 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCCMConcord Medical ServicesN/AN/AN/AN/AN/AKDLYKindly MDN/AN/AN/AN/AN/ANAKAKindlyMDN/AN/AN/AN/AN/ASERASera PrognosticsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCCMConcord Medical Services1.670.460.45KDLYKindly MDN/A5.435.42NAKAKindlyMDN/A13.0013.00SERASera PrognosticsN/A1.731.73Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCCMConcord Medical ServicesN/AKDLYKindly MDN/ANAKAKindlyMDN/ASERASera Prognostics54.64%Insider OwnershipCompanyInsider OwnershipCCMConcord Medical Services46.50%KDLYKindly MD50.50%NAKAKindlyMD40.79%SERASera Prognostics13.50%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCCMConcord Medical Services9704.34 million2.32 millionNot OptionableKDLYKindly MDN/A6.02 million2.96 millionN/ANAKAKindlyMDN/A7.61 million4.50 millionN/ASERASera Prognostics12037.67 million32.59 millionOptionableCCM, KDLY, SERA, and NAKA HeadlinesRecent News About These CompaniesSera Prognostics (NASDAQ:SERA) Lowered to Sell Rating by Wall Street ZenAugust 10, 2025 | marketbeat.comSera Prognostics, Inc. (NASDAQ:SERA) Q2 2025 Earnings Call TranscriptAugust 8, 2025 | msn.comSera Prognostics outlines European expansion and new commercial hires while targeting PreTRM Test reimbursement pilotsAugust 7, 2025 | msn.comSera Prognostics, Inc. (SERA) Q2 2025 Earnings Call TranscriptAugust 7, 2025 | seekingalpha.comSera Prognostics (SERA) Q2 Loss Down 4%August 6, 2025 | fool.comSera Prognostics, Inc. (SERA) Reports Q2 Loss, Lags Revenue EstimatesAugust 6, 2025 | zacks.comSERA PROGNOSTICS REPORTS SECOND QUARTER 2025 FINANCIAL RESULTSAugust 6, 2025 | prnewswire.comSera Prognostics (SERA) Expected to Announce Quarterly Earnings on WednesdayJuly 31, 2025 | marketbeat.comSera Prognostics Announces Conference Call and Webcast of Second Quarter Fiscal Year 2025 Financial Results on August 6, 2025July 29, 2025 | prnewswire.comPerkins Capital Management Inc. Takes $522,000 Position in Sera Prognostics, Inc. (NASDAQ:SERA)July 28, 2025 | marketbeat.comSera Prognostics director Mirza sells $552 in stockJuly 10, 2025 | investing.comSera Prognostics (NASDAQ:SERA) Stock, Insider Trading ActivityJune 30, 2025 | benzinga.comSera Prognostics: PreTRM Labor Test Should Represent Advance In Risk AssessmentJune 30, 2025 | seekingalpha.comSera Prognostics, Inc. (NASDAQ:SERA) CEO Sells $32,950.06 in StockJune 12, 2025 | insidertrades.comWe Think Sera Prognostics (NASDAQ:SERA) Needs To Drive Business Growth CarefullyJune 10, 2025 | finance.yahoo.comsera prognostics announces board elections and auditor ratificationJune 7, 2025 | investing.comAfter Plunging 43.9% in 4 Weeks, Here's Why the Trend Might Reverse for Sera Prognostics (SERA)May 29, 2025 | zacks.comSERA PROGNOSTICS TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCESMay 29, 2025 | prnewswire.comSera Prognostics, Inc.: Sera Prognostics Reports First Quarter 2025 Financial ResultsMay 26, 2025 | finanznachrichten.deSERA PROGNOSTICS TO PRESENT AT RBC GLOBAL HEALTHCARE CONFERENCEMay 14, 2025 | prnewswire.comSera Prognostics, Inc. (NASDAQ:SERA) Q1 2025 Earnings Call TranscriptMay 13, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCCM, KDLY, SERA, and NAKA Company DescriptionsConcord Medical Services NYSE:CCM$5.20 -0.30 (-5.45%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. It operates in two segments, Network and Hospital. The company's services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services. Its other treatments and diagnostic services comprise positron emission tomography-computed tomography and magnetic resonance imaging scanners. In addition, the company provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, as well as helps to recruit and determine the compensation of doctors and other medical personnel. Further, it offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, the company operates specialty cancer hospitals, which offers radiation, imaging, test laboratory, inpatient, and nursing services. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, the People's Republic of China.Kindly MD NASDAQ:KDLY$13.25 +2.16 (+19.48%) As of 08/13/2025Kindly MD, Inc. provides healthcare services. Its services include medication management, behavioral healthcare and alternative treatments. The firm offers evaluation and management, including chronic pain, functional medicine, cognitive behavioral therapy, trauma and addiction therapy, recovery support services, overdose education efforts, peer support, limited urgent care, preventative medicine, travel services, and hormone therapy. The company was founded by Timothy Pickett in December 2019 and is headquartered in Murray, UT.KindlyMD NASDAQ:NAKA$15.02 +1.77 (+13.36%) As of 04:00 PM EasternKindly MD, Inc. (“KindlyMD” or “Kindly”) is a Utah company formed in 2019. KindlyMD is a healthcare data company, focused on holistic pain management and reducing the impact of the opioid epidemic. KindlyMD offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Kindly believes these methods will help prevent and reduce addiction and dependency on opiates. Our specialty outpatient clinical services are offered on a fee-for-service basis. The Company offers evaluation and management, including, but not limited to chronic pain, functional medicine, cognitive behavioral therapy, trauma and addiction therapy, recovery support services, overdose education efforts, peer support, limited urgent care, preventative medicine, medically managed weight loss, and hormone therapy. Through its focus on an embedded model of prescriber and therapist teams, KindlyMD develops patient-specific care programs with a specific mission to reduce opioid use in the patient population while successfully treating patients with effective and evidence-based non-opioid alternatives in close conjunction with behavioral therapy. Beyond its treatment of patients, KindlyMD collects data focused on why and how patients turn to alternative treatments to reduce prescription medication use and addiction. The Company captures all relevant datapoints to assist and appropriately treat each individual patient. This also results in valuable data for the Company and the Company’s investors. We strive to become a source for evidence-based guidelines, data, treatment models, and education in the fight against the opioid crisis in America. Business Revenue Streams We currently earn revenue through (i) patient care services related to medical evaluation and treatment and (ii) product retail sales. Our forecasted plan is to operate across various revenue streams: (i) medical evaluation and treatment visits reimbursed by Medicare, Medicaid, and commercial insurance payers as well as self-pay services, (ii) data collection and research, (iii) education partnerships, (iv) service affiliate agreements, and (v) retail sales. Our principal executive offices are located at 5097 S 900 E, Suite 100 Salt Lake City, UT.Sera Prognostics NASDAQ:SERA$2.25 -0.05 (-2.17%) Closing price 04:00 PM EasternExtended Trading$2.22 -0.02 (-1.11%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes in the United States. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions, including preterm birth, preeclampsia, molecular time-to-birth, predictive analytics, gestational diabetes mellitus, fetal growth restriction, stillbirth, and postpartum depression. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Deere’s Sell-Off Could Be a Long-Term Buying Chance Cisco Systems: The Only AI Stock Income Investors Need to Own Gartner’s RSI Just Sank to 11: That’s a Setup You Can’t Ignore How Did Peter Thiel-Backed Crypto Exchange Bullish's IPO Go? Mercury Systems Up 27%: Financials Send Investors a Clear Signal Brinker Serves Up Earnings Beat, Sidesteps Cost Pressures CAVA’s Honeymoon Ends With a 16% Stock Drop Rigetti Stock: A Long-Term Quantum Play Facing Short-Term Tests Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access